Zentalis Pharmaceuticals - 54 Year Dividend History | ZNTL
Historical dividend payout and yield for Zentalis Pharmaceuticals (ZNTL) since 1971. The current TTM dividend payout for Zentalis Pharmaceuticals (ZNTL) as of January 31, 2025 is $0.00. The current dividend yield for Zentalis Pharmaceuticals as of January 31, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.135B |
$0.000B |
|
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics targeting cancers. The company's lead programs consist of ZN-c5, an oral selective estrogen receptor degrader for estrogen-receptor-positive, HER2-negative breast cancer which is in clinical stage. It operates principally in New York and San Diego. Zentalis Pharmaceuticals, Inc. is based in NEW YORK.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
